New Jersey A 277: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*

Status: Approved P.L.2021, c.285. (as of 2021-11-08)

State: New Jersey · Session: 219 · Bill: A 277

Subjects: PHARMACEUTIC

Sponsors: Armato, John, Karabinchak, Robert J., Singleton, Troy, Turner, Shirley K., Downey, Joann, Freiman, Roy

View New Jersey A 277 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.